Global Burden of Fungal Infections and Antifungal Resistance from 1961 to 2024: Findings and Future Implications

Journals Menu

Follow SCIRP

ISSN Print: 2157-9423
ISSN Online: 2157-9431
www.scirp.org/journal/pp
E-mail: pp@scirp.org

"Global Burden of Fungal Infections and Antifungal Resistance from 1961 to 2024: Findings and Future Implications"
written by Steward Mudenda,
published by Pharmacology & Pharmacy, Vol.15 No.4, 2024

has been cited by the following article(s):

No relevant information.

[1]	Environmental microbiome, human fungal pathogens, and antimicrobial resistance Trends in Microbiology, 2025 DOI:10.1016/j.tim.2024.08.003

[2]	Fabrication of chitosan-coated ciprofloxacin drug nanocomposite for combating antibacterial and respiratory infection leading to sepsis Journal of Materials Research, 2025 DOI:10.1557/s43578-024-01507-1

[3]	The Significance of Mono‐ and Dual‐Effective Agents in the Development of New Antifungal Strategies Chemical Biology & Drug Design, 2025 DOI:10.1111/cbdd.70045

[4]	Biomimetic Antifungal Materials: Countering the Challenge of Multidrug-Resistant Fungi Biomimetics, 2024 DOI:10.3390/biomimetics9070425

Follow SCIRP